Description: Robert Stein is KineMed CEO. With a Lead411 subscription, KineMed email addresses ( @kinemed.com ) of the executives are viewable. Other information includes Robert Stein email, phone, and extension.
Be sure to check our Linkedin tab on the company page. Typical management titles include VP, Chief, Vice President, Director, manager, & more. Similar names to Stein can be found at Executive Directory - Stein.
Robert Stein MD, PhD, Named CEO of KineMed 1/1/08 Repositioning Idle Drugs via Systematic Serendipity; Systems-based Approaches for Boosting Stalled Drugs 10/11/07 KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model 8/28/07 KineMed to Collaborate with Merck KGaA to Validate New Applications for Drug Development Candidates; Technology to be Applied to Both Clinical- and Preclinical-Stage Compounds in Merck KGaA Pipeline more... Publications General Articles of Interest | Measurement of Cell Proliferation | HIV/AIDS T-Cell Kinetics and Lifespan | Measurement of Protein Synthesis and Degradation | Fuel Selection/Carbohydrate, Lipid and Cholesterol Metabolism | Advances in Mass Spectrometry Applications | Toxicology General Articles of Interest Whole-Body Glycolysis Measured by the Deuterated-Glucose Disposal Test Correlates Highly With Insulin Resistance In Vivo Diabetes Care. Diabetes Care, 2007; 30 (5):1143-1149 Emerging applications of kinetic biomarkers in preclinical and clinical drug development.
